[Ip-health] Frontline India on Bayer CL (and Novartis)

Baker, Brook b.baker at neu.edu
Wed Apr 18 07:56:27 PDT 2012


A series of good articles in a leading Indian periodical on the Bayer CL and related issues including Novartis.
The full issue is here: http://www.flonnet.com/
Patent to plunder<http://www.flonnet.com/stories/20120504290800400.htm>
A big step forward<http://www.flonnet.com/stories/20120504290801000.htm>
Patents and the law<http://www.flonnet.com/stories/20120504290801300.htm>
A welcome first<http://www.flonnet.com/stories/20120504290801600.htm>
Western warnings<http://www.flonnet.com/stories/20120504290801800.htm>
Question of efficacy<http://www.flonnet.com/stories/20120504290802200.htm>
Interview:<http://www.flonnet.com/stories/20120504290802600.htm> Shamnad Basheer
Drug and duplicity<http://www.flonnet.com/stories/20120504290802800.htm>

Professor Brook K. Baker

Health GAP (Global Access Project)
Northeastern U. School of Law
Program on Human Rights and the Global Economy
400 Huntington Ave.
Boston, MA 02115 USA
Honorary Research Fellow, University of KwaZulu Natal, Durban, S. Africa
(w) 617-373-3217
(cell) 617-259-0760
(fax) 617-373-5056
b.baker at neu.edu







More information about the Ip-health mailing list